Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity

References

• Aleksunes LM, Augustine LM, Scheffer GL, Cherrington NJ, Manautou JE. (2008). Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250:82–88.
   PubMed Web of Science ®Google Scholar
• Andersson BS, Aw TY, Jones DP. (1987). Mitochondrial transmembrane potential and pH gradient during anoxia. Am J Physiol 252:C349–C355.
   PubMed Web of Science ®Google Scholar
• Badary OA, Abdel-Maksoud S, Ahmed WA, Owieda GH. (2005). Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 76:2125–2135.
   PubMed Web of Science ®Google Scholar
• Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. (2003). Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 142:178–186.
   PubMed Web of Science ®Google Scholar
• Barabas K, Milner R, Lurie D, Adin C. (2008). Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 6:1–18.
   PubMed Web of Science ®Google Scholar
• Boom SP, Gribnau FW, Russel FG. (1992). Organic cation transport and cationic drug interactions in freshly isolated proximal tubular cells of the rat. J Pharmacol Exp Ther 263:445–450.
   PubMed Web of Science ®Google Scholar
• Boveris A, Fraga CG, Varsavsky AI, Koch OR. (1983). Increased chemiluminescence and superoxide production in the liver of chronically ethanol-treated rats. Arch Biochem Biophys 227:534–541.
   PubMed Web of Science ®Google Scholar
• Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Pérez JM. (2007). Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7:3–18.
   PubMed Web of Science ®Google Scholar
• Chirino YI, Pedraza-Chaverri J. (2009). Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61:223–242.
   PubMed Web of Science ®Google Scholar
• Ekström G, Ingelman-Sundberg M. (1989). Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313–1319.
   PubMed Web of Science ®Google Scholar
• Everse J, Reich RM, Kaplan NO, Finn WD. (1975). New instrument for rapid determination of activities of lactate dehydrogenase isoenzymes. Clin Chem 21:1277–1281.
   PubMed Web of Science ®Google Scholar
• Francescato HD, Costa RS, Scavone C, Coimbra TM. (2007). Parthenolide reduces cisplatin-induced renal damage. Toxicology 230:64–75.
   PubMed Web of Science ®Google Scholar
• Fuertes MA, Castilla J, Alonso C, Pérez JM. (2003). Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10:257–266.
   PubMed Web of Science ®Google Scholar
• Gill A, Wortham K, Costa D, Davis W, Ticho B, Whalley E. (2009). Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats. Am J Nephrol 30:521–526.
   PubMedGoogle Scholar
• Guerrero-Beltrán CE, Calderón-Oliver M, Tapia E, Medina-Campos ON, Sánchez-González DJ, Martínez-Martínez CM, Ortiz-Vega KM, Franco M, Pedraza-Chaverri J. (2010). Sulforaphane protects against cisplatin-induced nephrotoxicity. Toxicol Lett 192:278–285.
   PubMed Web of Science ®Google Scholar
• Halliwell B. (2006). Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 141:312–322.
   PubMed Web of Science ®Google Scholar
• Joy J, Nair CK. (2008). Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. J Cancer Res Ther 4:111–115.
   PubMed Web of Science ®Google Scholar
• Kaushal GP, Kaushal V, Hong X, Shah SV. (2001). Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 60:1726–1736.
   PubMed Web of Science ®Google Scholar
• Khan S, O’Brien PJ. (1991). 1-bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem Biophys Res Commun 179:436–441.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim YW, Oh YJ, Back NI, Chung SA, Chung HG, Jeong TS, Choi MS, Lee KT. (2006). Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull 29:2436–2441.
   PubMed Web of Science ®Google Scholar
• Kruidering M, Van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. (1997). Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 280:638–649.
   PubMed Web of Science ®Google Scholar
• Lau AH. (1999). Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int 56:1295–1298.
   PubMed Web of Science ®Google Scholar
• Lebwohl D, Canetta R. (1998). Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34:1522–1534.
   PubMed Web of Science ®Google Scholar
• Leibbrandt ME, Wolfgang GH, Metz AL, Ozobia AA, Haskins JR. (1995). Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 48:761–770.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. (2006). Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 89:515–523.
   PubMed Web of Science ®Google Scholar
• McGuinness SJ, Ryan MP. (1994). Mechanism of cisplatin nephrotoxicity in rat renal proximal tubule suspensions. Toxicol in Vitro 8:1203–1212.
   PubMedGoogle Scholar
• Minamiyama Y, Takemura S, Toyokuni S, Nishino Y, Yamasaki K, Hai S, Yamamoto S, Okada S. (2002). Amelioration of cisplatin toxicity by a fermented grain food product. Biofactors 16:105–115.
   PubMedGoogle Scholar
• Mohan IK, Khan M, Shobha JC, Naidu MU, Prayag A, Kuppusamy P, Kutala VK. (2006). Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother Pharmacol 58:802–808.
   PubMed Web of Science ®Google Scholar
• Nechay BR, Neldon SL. (1984). Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid. Cancer Treat Rep 68:1135–1141.
   PubMedGoogle Scholar
• Nishikawa M, Nagatomi H, Chang BJ, Sato E, Inoue M. (2001). Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction inuduced by cisplatin. Arch Biochem Biophys 387:78–84.
   PubMed Web of Science ®Google Scholar
• Nowak G. (2002). Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 277:43377–43388.
   PubMed Web of Science ®Google Scholar
• Pérez-Rojas JM, Cruz C, García-López P, Sánchez-González DJ, Martínez-Martínez CM, Ceballos G, Espinosa M, Meléndez-Zajgla J, Pedraza-Chaverri J. (2009). Renoprotection by alpha-Mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic Res 43:1122–1132.
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Eskandari MR, Shakibaei R, Kamalinejad M. (2010a). A search for hepatoprotective activity of aqueous extract of Rhus coriaria L. against oxidative stress cytotoxicity. Food Chem Toxicol 48:854–858.
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Eskandari MR, Shakibaei R, Kamalinejad M. (2010b). A search for hepatoprotective activity of fruit extract of Mangifera indica L. against oxidative stress cytotoxicity. Plant Foods Hum Nutr 65:83–89.
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Khan S, O’Brien PJ. (2001). Lysosomal oxidative stress cytotoxicity induced by nitrofurantoin redox cycling in hepatocytes. Adv Exp Med Biol 500:261–265.
   PubMed Web of Science ®Google Scholar
• Rashba-Step J, Turro NJ, Cederbaum AI. (1993). Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch Biochem Biophys 300:401–408.
   PubMed Web of Science ®Google Scholar
• Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. (2002). Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 48:309–315.
   PubMed Web of Science ®Google Scholar
• Sakahira H, Enari M, Nagata S. (1998). Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96–99.
   PubMed Web of Science ®Google Scholar
• Sánchez-Pérez Y, Morales-Bárcenas R, García-Cuellar CM, López-Marure R, Calderon-Oliver M, Pedraza-Chaverri J, Chirino YI. (2010). The alpha-mangostin prevention on cisplatin-induced apoptotic death in LLC-PK1 cells is associated to an inhibition of ROS production and p53 induction. Chem Biol Interact [Epub ahead of print].
   PubMedGoogle Scholar
• Sastry J, Kellie SJ. (2005). Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 22:441–445.
   PubMed Web of Science ®Google Scholar
• Somani SM, Husain K, Jagannathan R, Rybak LP. (2001). Amelioration of cisplatin-induced oto and nephrotoxicity by protective agents. Ann. Neurosci 8:101–13.
   Google Scholar
• Zhou H, Kato A, Miyaji T, Yasuda H, Fujigaki Y, Yamamoto T, Yonemura K, Takebayashi S, Mineta H, Hishida A. (2006). Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats. Nephrol Dial Transplant 21:616–623.
   PubMed Web of Science ®Google Scholar